» Articles » PMID: 18050283

Papillary Thyroid Microcarcinoma: Prognostic Factors and Treatment

Overview
Journal J Surg Oncol
Date 2007 Dec 1
PMID 18050283
Citations 38
Authors
Affiliations
Soon will be listed here.
Abstract

Background And Objectives: Within the group of patients with papillary thyroid microcarcinoma (PTMC), the prognostic factors have not been well defined and the optimal treatment has not been proved. The aim of this study was to find out the factors associated with the tumor recurrence in the patients with PTMC.

Methods: A total of 228 patients with PTMC (189 females, 39 males; age 14-85 years, median 46 years) were treated at our Institute between 1975 and 2006. The data on patients' gender, age, extent of disease, pathomorphological characteristics, therapy, locoregional control, disease-free survival and disease-specific survival were collected. Statistical correlation between possible prognostic factors and the duration of disease-free interval was analyzed by univariate and Cox's multivariate survival analysis.

Results: The tumor diameter ranged from 0.1 to 10 mm (mean 6.1 mm). The median length of observation was 84 months (range 1-385). During the follow-up period, the recurrence was diagnosed in 7 patients (6 locoregional and 1 distant). Multivariate analysis showed that tumor size and lymph node metastases were independent prognostic factors for disease-free interval.

Conclusions: Longer disease-free interval was found in the patients with a tumor diameter < or =6 mm and without lymph-node metastases.

Citing Articles

The impact of lymph node ratio on disease recurrence in papillary thyroid microcarcinoma.

de Jong M, Mahipal M, Ngiam K, Tan W, Yang S, Parameswaran R Ann R Coll Surg Engl. 2023; 105(7):632-638.

PMID: 37652084 PMC: 10471441. DOI: 10.1308/rcsann.2022.0094.


Correlation between Sonographic Features and Central Neck Lymph Node Metastasis in Solitary Solid Papillary Thyroid Microcarcinoma with a Taller-Than-Wide Shape.

Chen S, Jiang X, Zheng W, Luo Y Diagnostics (Basel). 2023; 13(5).

PMID: 36900093 PMC: 10001029. DOI: 10.3390/diagnostics13050949.


Bibliometric insights in advances of papillary thyroid microcarcinoma: Research situation, hot points, and global trends.

Chen K, Wang Z, Sun W, Zhang D, Zhang T, He L Front Endocrinol (Lausanne). 2022; 13:949993.

PMID: 36004350 PMC: 9393698. DOI: 10.3389/fendo.2022.949993.


Minimal extrathyroidal extension is associated with lymph node metastasis in single papillary thyroid microcarcinoma: a retrospective analysis of 814 patients.

Song R, Kim H, Kang K World J Surg Oncol. 2022; 20(1):170.

PMID: 35643530 PMC: 9148524. DOI: 10.1186/s12957-022-02629-8.


Is Gross Extrathyroidal Extension to Strap Muscles (T3b) Only a Risk Factor for Recurrence in Papillary Thyroid Carcinoma? A Propensity Score Matching Study.

Kim Y, Kim Y, Bae J, Kim J, Kim K Cancers (Basel). 2022; 14(10).

PMID: 35625974 PMC: 9139627. DOI: 10.3390/cancers14102370.